Business Wire - Mylan Announces Approvals
Thursday, November 13th, 2008 Business &Medical Editors
PITTSBURGH–(BUSINESS WIRE)–Feb. 17, 2000
Mylan Laboratories Inc. (NYSE:MYL) announced today that it has received final approval to manufacture and market Terazosin Hydrochloride Capsules in 1mg, 2mg, 5mg, and 10mg strengths.
Terazosin is the generic equivalent to Hytrin(R), an alpha-1…
